|Study Description:||The goal of this clinical research study is to learn about the safety of |
IPI-145 and find the highest tolerable dose that can be given to patients with
advanced blood cancer.
IPI-145 is designed to block the normal signals in blood cells that tell the
cells to divide and grow. This may cause cancer cells to stop growing and/or